NCT03745274View on ClinicalTrials.gov

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 19, 2008

Primary Completion Date

May 27, 2009

Study Completion Date

May 27, 2009

Conditions
Influenza, Avian
Interventions
BIOLOGICAL

GHB04L1

Solution

OTHER

Placebo

Buffer solution

Trial Locations (1)

197376

Research Institute of Influenza, Russian Academy of Medical Sciences, Saint Petersburg

Sponsors
All Listed Sponsors
lead

AVIR Green Hills Biotechnology AG

INDUSTRY

NCT03745274 - Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults | Biotech Hunter | Biotech Hunter